Alucent raises $35m for natural vascular scaffolding clinical trials
AlucentNVS technology is a combination drug-device therapy. (Credit: Chokniti Khongchum from Pixabay)
NS Medical Devices is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X